· Executive systems brief
Field note 04IBS Awareness Month 2026
Replace diagnostic drift with a consistent route for evaluation, symptom management, and follow-up.
A common disorder still gets an inconsistent route.
People with recurring abdominal pain and bowel changes may cycle through urgent visits, restrictive diets, testing, and self-management without a clear explanation, warning-sign review, or longitudinal plan.
Leaders can standardize a positive diagnostic approach, appropriate testing, dietitian and behavioral support, medication review, and reassessment while preventing both overtesting and dismissal.
Audit repeat visits for abdominal pain with bowel change and identify where appropriate evaluation, diagnosis, education, or follow-up fails.
IFFGD estimates that IBS affects about 5% to 10% of people and notes that many remain undiagnosed.
NIDDK describes repeated abdominal pain with bowel-movement changes that may involve diarrhea, constipation, or both.
NIDDK states that IBS symptoms occur without visible signs of damage or disease in the digestive tract.
Connect recognition, appropriate evaluation, and individualized management.
A reliable pathway confirms the symptom pattern, checks warning signs, and makes treatment iterative.
- 01
Recognize and screen
Capture pain, stool pattern, duration, diet, medications, psychosocial context, and warning signs.
- 02
Evaluate appropriately
Use clinical criteria and targeted testing based on age, history, examination, and warning signs.
- 03
Build the plan
Offer understandable options for diet, medications, activity, gut-brain therapies, and self-management.
- 04
Reassess and adapt
Track symptom burden, nutrition, function, adverse effects, and new warning signs.
Operating rule: IBS is a real disorder of gut-brain interaction. A normal test does not mean symptoms are imagined, and indiscriminate exclusion testing is not a care plan.
Measure diagnostic clarity and functional improvement.
Stratify by age, sex, race and ethnicity, language, disability, payer, geography, and access to nutrition and behavioral health services.
Structured assessment
Track complete symptom and warning-sign review.
Diagnostic clarity
Measure whether patients leave with a diagnosis or defined next step.
Support access
Follow referrals to nutrition, behavioral, and specialty services.
Function
Measure symptom and daily-life outcomes.
Transfer the pattern, not just the complaint.
The receiver needs symptom chronology, warning signs, prior testing, treatments, nutrition risks, and the patient’s goals.
Primary care to gastroenterology
- Send the structured symptom pattern.
- Include completed tests and warning-sign assessment.
- State the unresolved clinical question.
Clinician to dietitian or therapist
- Share diagnosis, subtype, and nutrition status.
- Avoid vague instructions to eliminate foods.
- Align goals and follow-up with the prescribing clinician.
Treatment to reassessment
- Document expected benefit and trial length.
- Track adverse effects and restrictive eating risk.
- Escalate new warning signs promptly.
Dietary restriction without assessment and monitoring can create nutritional harm and should not become the default response.
Ask whether clarity replaces repeat utilization.
Review repeat acute-care use, duplicative testing, and patient-reported function together.
Swipe or use arrow keys to view all columns.
| Signal | Executive question | Accountable owner | Cadence |
|---|---|---|---|
| Recognition | Are clinicians capturing the information needed for a safe positive diagnosis? | Primary care and gastroenterology | Monthly |
| Clarity | How often does evaluation end in unresolved uncertainty? | Gastroenterology and quality | Quarterly |
| Access | Which evidence-based supports remain practically unavailable? | Access and care management | Monthly |
| Outcome | Is care improving life rather than only generating tests? | Clinical leaders | Quarterly |
Create one consistent IBS pathway.
Include patients, primary care, gastroenterology, dietetics, behavioral health, and pharmacy.
Map variation
- Review repeat visits and duplicative testing.
- Baseline warning-sign documentation and follow-up.
- Identify nutrition and behavioral-health access gaps.
Standardize assessment
- Deploy a symptom and warning-sign template.
- Create targeted referral criteria.
- Provide plain-language self-management and safety-net guidance.
Measure what changes
- Track diagnostic clarity and function.
- Review restrictive-diet risk and unresolved cases.
- Scale the reliable steps.
Clarity is part of treatment.
IBS Awareness Month 2026 gives executives a chance to reduce diagnostic drift and make appropriate, respectful, outcome-focused care easier to navigate.
Authoritative resources
- IBS Awareness Month, International Foundation for Gastrointestinal Disorders
- IBS definition and facts, National Institute of Diabetes and Digestive and Kidney Diseases
- IBS symptoms and causes, National Institute of Diabetes and Digestive and Kidney Diseases
- IBS diagnosis, National Institute of Diabetes and Digestive and Kidney Diseases
- IBS treatment, National Institute of Diabetes and Digestive and Kidney Diseases
- Irritable Bowel Syndrome, American College of Gastroenterology
Safety note: IBS-like symptoms can overlap with other conditions. Blood in stool, black stool, persistent fever, unexplained weight loss, anemia, severe or worsening pain, dehydration, new symptoms at an older age, or a strong family history of gastrointestinal disease needs clinical evaluation. Call 911 for severe bleeding, fainting, or another life-threatening emergency.
IFFGD confirms April and uses the official short name IBS Awareness Month. No distinct 2026 IFFGD campaign theme was published on the observance page, so older annual slogans are not carried forward.